Akero Therapeutics, Inc. Insider Transactions
Akero Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Yale Catriona
Chief Development Officer |
Sell | 25,907 @ $55.15 | $1.43 M | 118,815 | 01/27/2025 | 01/31/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 14,467 @ $55.95 | $809.43 K | 104,348 | 01/27/2025 | 01/31/2025 | |
|
Yale Catriona
Chief Development Officer |
Sell | 8,700 @ $57.01 | $495.96 K | 95,648 | 01/27/2025 | 01/31/2025 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 13,812 @ $54.76 | $756.35 K | 187,675 | 01/27/2025 | 01/29/2025 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 5,059 @ $55.62 | $281.38 K | 182,616 | 01/27/2025 | 01/29/2025 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 12,379 @ $56.97 | $705.23 K | 170,237 | 01/27/2025 | 01/29/2025 | |
|
Lamy Patrick
Senior VP, Commercial Strategy |
Sell | 5,000 @ $57.03 | $285.15 K | 33,492 | 01/27/2025 | 01/29/2025 | |
|
Young Jonathan
COO |
Sell | 10,000 @ $28.03 | $280.33 K | 218,083 | 01/02/2025 | 01/06/2025 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 3,800 @ $31.10 | $118.17 K | 178,337 | 12/17/2024 | 12/18/2024 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 3,800 @ $31.10 | $118.17 K | 178,337 | 12/17/2024 | 12/18/2024 | |
|
Yale Catriona
Chief Development Officer |
Sell | 9,074 @ $29.11 | $264.12 K | 95,648 | 12/16/2024 | 12/18/2024 | |
|
Lamy Patrick
Senior VP, Commercial Strategy |
Sell | 1,000 @ $29.13 | $29.13 K | 34,258 | 12/16/2024 | 12/18/2024 | |
|
Yale Catriona
Chief Development Officer |
Sell | 9,074 @ $29.11 | $264.12 K | 95,648 | 12/16/2024 | 12/18/2024 | |
|
Lamy Patrick
Senior VP, Commercial Strategy |
Sell | 1,000 @ $29.13 | $29.13 K | 34,258 | 12/16/2024 | 12/18/2024 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 2,368 @ $30.79 | $72.91 K | 178,337 | 12/10/2024 | 12/12/2024 | |
|
Rolph Timothy
Chief Scientific Officer |
Sell | 2,450 @ $31.03 | $76.02 K | 178,337 | 12/10/2024 | 12/12/2024 | |
|
Young Jonathan
COO |
Sell | 2,503 @ $30.79 | $77.07 K | 203,783 | 12/10/2024 | 12/12/2024 | |
|
Lamy Patrick
Senior VP, Commercial Strategy |
Sell | 925 @ $30.79 | $28.48 K | 17,858 | 12/10/2024 | 12/12/2024 | |
|
Yale Catriona
Chief Development Officer |
Sell | 2,810 @ $30.79 | $86.52 K | 71,348 | 12/10/2024 | 12/12/2024 | |
| Sell | 2,817 @ $30.79 | $86.74 K | 38,335 | 12/10/2024 | 12/12/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akero Therapeutics, Inc. FAQ's
The list of insiders at Akero Therapeutics, Inc. includes Lamy Patrick, Yale Catriona, Rolph Timothy, Young Jonathan, Cheng Andrew, Graham G. Walmsley, White William Richard.
Insiders have sold a total of 419.31 K Akero Therapeutics, Inc. shares in the last 12 months for a total of 20.22 M sold.
The following insiders have sold Akero Therapeutics, Inc. shares in the last 12 months: Lamy Patrick ($391.50 K), Yale Catriona ($7.25 M), Rolph Timothy ($3.84 M), Young Jonathan ($3.09 M), Cheng Andrew ($5.62 M), White William Richard ($30.34 K),
Insiders have purchased a total of 400.00 K Akero Therapeutics, Inc. shares in the last 12 months for a total of 18.39 M.
The following insiders have purchased Akero Therapeutics, Inc. shares in the last 12 months: Graham G. Walmsley ($18.39 M),